Investors in D extension include Siemens Venture Capital and Fidelity Biosciences.

AxioMed Spine, a spinal orthopedics company backed by corporate venturing unit Cleveland Clinic Innovations, has extended by $5m its series D round.

Investors in D extension include Siemens Venture Capital, the corporate venturing unit of the eponymous Germany-based industrial conglomerate, Fidelity Biosciences, which has the eponymous mutual fund manager as its limited partner, and venture capital firms Aisling Capital, Kearny Venture Partners and OrbiMed Advisors, according to news provider PEHub.

Founded in 2001, AxioMed’s website said it had raised $34m in total and said its other investors included Thomas McNerney & Partners, Reservoir Venture Partners, Primus Capital Funds, MB Venture Partners, Investor Growth Capital, Early Stage Partners and CID Equity Partners.

AxioMed’s earlier round raised $14.5m in July 2010.